Mol Cancer. 2024 Oct 7;23(1):224. doi: 10.1186/s12943-024-02125-5.
PMID:39375715
Sequential Targeting in Multiple Myeloma: Talquetamab, a GPRC5D bispecific antibody, as a Bridge to BCMA CAR-T cell therapy.
Dhakal B, Akhtar OS, Fandrei D, Jensen A, Banerjee R, Pan D, Richard S, Friend R, Rees MJ, Costello P, Vazquez Martinez MA, Pasvolsky O, Wagner CB, Davis JA, Castaneda Puglianini OA, Reshef R, Afrough A, Dima D, Bhutani M, Nadeem O, Parrondo RD, Freeman CL, Mikkilineni L, Raza S, Anderson LD Jr, Kapoor P, Hosoya H, Chhabra S, Grajales-Cruz A, Gaballa MR, Midha S, Alsina M, Sborov DW, Patel KK, Lin Y, Ferreri CJ, Gagelmann N, Kumar AD, Hansen DK, Cowan AJ, Costa LJ, Merz M, Sidana S.
Blood. 2025 Aug 1:blood.2025029773. doi: 10.1182/blood.2025029773. Online ahead of print.
PMID:40749169
Core GRADE 4: rating certainty of evidence-risk of bias, publication bias, and reasons for rating up certainty.
Guyatt G, Wang Y, Eachempati P, Iorio A, Murad MH, Hultcrantz M, Chu DK, Florez ID, Hemkens LG, Agoritsas T, Yao L, Vandvik PO, Montori VM, Brignardello-Petersen R.
BMJ. 2025 May 13;389:e083864. doi: 10.1136/bmj-2024-083864.
PMID:40360206
The Role of Radiotherapy in the Treatment of Higher-Grade Meningioma.
Lee G, Shih HA.
Neurosurg Clin N Am. 2023 Jul;34(3):463-478. doi: 10.1016/j.nec.2023.02.013. Epub 2023 Mar 27.